Drawing for KIPZA

USPTO serial 79344250

KIPZA

Reviewed by CopyMark Law Group

Reg. 7265277Status 700Registered
Filing date
Status date
Registration date
Jan 9, 2024
Examiner
SALCIDO, JOHN CHARLES
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KIPZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jong Park

Jong Park The PL Law Group, PLLC13800 Coppermine Rd., FL 1-3Herndon, VA 20171UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Disinfectants for household use; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating diabetes; Dietetic foods for treating diabetics; pharmaceutical agents affecting peripheral nervous system; vitamin preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment and prevention of chronic pain of musculoskeletal joints; Medicated ointments for treating dermatological conditions; disinfectants for medical apparatus and instruments; pharmaceutical drugs for the treatment and prevention of chronic pain of musculoskeletal joints; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis purposes; analgesics; anti-viral agents; antibiotic preparations; hypoglycemic agents; pharmaceutical preparations for treatment respiratory system disordersACTIVE—
010Prosthetic tissues for vascular use; glycated hemoglobin measuring apparatus; pulse measuring devices; [ prosthetic implants, namely, prosthetic ligaments, prosthetic sockets used to fasten prosthetic limbs to the body, prosthetic intraocular implants; ] biopsy needles; devices for measuring biological phenomena, * other than for dental purposes , * namely, medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; medical apparatus and instruments * , other than for dental purposes * for treating cardiovascular disease, use in orthopedic surgery, and use in performing biopsies; Blood testing apparatus, namely, blood sampling tubes for medical purposes; blood analysis device for tumor diagnosis; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; prosthetics for vascular embolization; vascular prosthesis; prosthetic tissues for visceral use; embolic devices for treating vascular anomalies; Medical apparatus for monitoring blood glucose levels; blood glucose testing apparatus for medical purposes; blood glucose meters; devices for measuring blood sugarACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2025INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
May 24, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 29, 2024NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Sep 24, 2024LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Sep 24, 2024COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Sep 24, 2024COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Sep 24, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 16, 2024LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 7, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 11, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 11, 2024FIMPFINAL DISPOSITION PROCESSED—
Apr 9, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 2, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 13, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 13, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 24, 2023GPNXNOTIFICATION PROCESSED BY IB—
Oct 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 4, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 31, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 31, 2023RFRRREFUSAL PROCESSED BY MPU—
Feb 11, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 10, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2023DOCKASSIGNED TO EXAMINER—
Jul 12, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 7, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance